This announcement is a separate document:
成都圣诺生物科技股份有限公司2023年度以简易程序向特定对象发行股票募集资金使用的可行性分析报告（修订稿）
Chengdu Shengnuo Biotechnology Co., Ltd.\'s 2023 Feasibility Analysis Report on Issuing Shares to Specific Targets Using Simple Procedures to Raise Funds (Revised Draft)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.